Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Verseon prepares for phase I study of oral anticoagulant VE-1902

June 14, 2018

MaxCyte and NIH enter CRADA for sickle cell disease

June 11, 2018

FDA approves Mircera for pediatric use

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...